Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiki Kayano

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Italian Journal of Pediatrics|October 17, 2012
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastomaYuya Sato, Hidemitsu Kurosawa, Keitaro Fukushima, et al.
Diagnostics (Basel, Switzerland)|September 5, 2020
Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk NeuroblastomaHiroshi Wakabayashi, Daiki Kayano, Anri Inaki, et al.
BMC Research Notes|December 21, 2017
Complete remission of metastatic pheochromocytoma in <sup>123</sup>I-metaiodobenzylguanidine scintigraphy after a single session of <sup>131</sup>I-metaiodobenzylguanidine therapy: a case reportTeruaki Sugino, Ryosuke Ando, Rei Unno, et al.
Endocrine Journal|September 13, 2014
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registryKeiichiro Yoshinaga, Noboru Oriuchi, Hiroshi Wakabayashi, et al.
Annals of Nuclear Medicine|December 6, 2021
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [<sup>131</sup>I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paragangliomaAnri Inaki, Tohru Shiga, Yoshito Tsushima, et al.
Annals of Nuclear Medicine|August 31, 2020
High-dose <sup>131</sup>I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experienceHiroshi Wakabayashi, Daiki Kayano, Anri Inaki, et al.
Annals of Nuclear Medicine|March 29, 2020
High-dose <sup>131</sup>I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in JapanDaiki Kayano, Hiroshi Wakabayashi, Kenichi Nakajima, et al.
Frontiers in Oncology|October 10, 2022
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE studyAkihiko Takeuchi, Makoto Endo, Akira Kawai, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Italian Journal of Pediatrics|October 17, 2012
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastomaYuya Sato, Hidemitsu Kurosawa, Keitaro Fukushima, et al.
Diagnostics (Basel, Switzerland)|September 5, 2020
Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk NeuroblastomaHiroshi Wakabayashi, Daiki Kayano, Anri Inaki, et al.
BMC Research Notes|December 21, 2017
Complete remission of metastatic pheochromocytoma in <sup>123</sup>I-metaiodobenzylguanidine scintigraphy after a single session of <sup>131</sup>I-metaiodobenzylguanidine therapy: a case reportTeruaki Sugino, Ryosuke Ando, Rei Unno, et al.
Endocrine Journal|September 13, 2014
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registryKeiichiro Yoshinaga, Noboru Oriuchi, Hiroshi Wakabayashi, et al.
Annals of Nuclear Medicine|December 6, 2021
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [<sup>131</sup>I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paragangliomaAnri Inaki, Tohru Shiga, Yoshito Tsushima, et al.
Annals of Nuclear Medicine|August 31, 2020
High-dose <sup>131</sup>I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experienceHiroshi Wakabayashi, Daiki Kayano, Anri Inaki, et al.
Annals of Nuclear Medicine|March 29, 2020
High-dose <sup>131</sup>I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in JapanDaiki Kayano, Hiroshi Wakabayashi, Kenichi Nakajima, et al.
Frontiers in Oncology|October 10, 2022
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE studyAkihiko Takeuchi, Makoto Endo, Akira Kawai, et al.
Pageof 4